Medical Devices

Powersports giant Massimo Group's stock plummets after announcing a bold but risky plan to acquire an AI firm and enter the health robotics market.

A next-gen immunotherapy enters trials, hoping its safer design can unlock the immune system and form a potent combo against advanced solid tumors.

Amid a relentless outbreak, Brazil launches a massive pilot program for the IXCHIQ® vaccine, a critical test for public health and global preparedness.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

A new partnership adds dedicated cellular connectivity to a hip-protecting airbag belt, offering seniors and caregivers unparalleled safety and peace of mind.

Death rates fall, but a new report reveals rising incidence and stark inequities. Can new drugs and AI reshape the future for all patients?

Alcon launches PRECISION7, a new one-week contact lens, creating a category that blends advanced comfort with an intuitive, affordable replacement schedule.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

JScreen, Manischewitz, and advocate Gila Pfeffer offer low-cost cancer and carrier genetic tests in NYC, transforming community health access.

Investors sue medical device maker Integer Holdings, alleging misleading statements led to a catastrophic 32% stock drop. What went wrong behind the scenes?

With its largest fund yet, the firm is doubling down on breakthrough biotech and medtech, signaling strong investor faith in deep science innovation.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

The Spanish biotech firm strengthens its IP for a novel aggression treatment, targeting a growing multi-billion dollar Japanese CNS market.

As CFO Scott Ullem preps for a key presentation, Edwards balances record innovation and strong financials against new regulatory hurdles. What's at stake?

Amid strategic uncertainty after a rejected takeover, STAAR Surgical appoints two veteran executives as interim co-CEOs while launching a global search.

India’s Polymatech signals a major U.S. market offensive, appointing a seasoned leader to drive growth and explore domestic manufacturing possibilities.

The medical tech firm has confirmed it's evaluating strategic options, including a non-binding offer from Steel Partners to acquire a 51% controlling stake.